Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Earnings Yield Over TimeElevated
Percentile Rank89
3Y CAGR-52.2%
Studio
Year-over-Year Change

Earnings yield ratio

3Y CAGR
-52.2%/yr
Annual compound
Percentile
P89
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
20251.93%+163.1%
2024-3.06%-366.8%
20231.15%-93.5%
202217.64%+190.2%
2021-19.57%-32.5%
2020-14.77%+45.5%
2019-27.08%-117.7%
2018-12.44%-21.2%
2017-10.26%-170.6%
2016-3.79%-